These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16568193)

  • 41. The role of peripheral ultrafiltration in the management of acute decompensated heart failure.
    Andrade JG; Stadnick E; Virani SA
    Blood Purif; 2010; 29(2):177-82. PubMed ID: 20093824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. What is evidence-based, what is new in medical therapy of acute heart failure?
    Grimm W
    Herz; 2006 Nov; 31(8):771-9. PubMed ID: 17149679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of acute decompensated heart failure: renal implications.
    Virani SA
    Blood Purif; 2008; 26(1):18-22. PubMed ID: 18182790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hospitalized patients with acute decompensated heart failure: recognition, risk stratification, and treatment review.
    Amin A
    J Hosp Med; 2008 Nov; 3(6 Suppl):S16-24. PubMed ID: 19084891
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Narrative review: the management of acute decompensated heart failure.
    Marik PE; Flemmer M
    J Intensive Care Med; 2012; 27(6):343-53. PubMed ID: 21616957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
    Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
    J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decrease in NTproBNP plasma levels indicates clinical improvement of acute decompensated heart failure.
    Di Somma S; Magrini L; Mazzone M; De Leva R; Tabacco F; Marino R; Talucci V; Ferri E; Forte P; Cardelli P; Gentiloni N; Pittoni V
    Am J Emerg Med; 2007 Mar; 25(3):335-9. PubMed ID: 17349910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bronchodilator therapy in acute decompensated heart failure patients without a history of chronic obstructive pulmonary disease.
    Singer AJ; Emerman C; Char DM; Heywood JT; Kirk JD; Hollander JE; Summers R; Lee CC; Wynne J; Kellerman L; Peacock WF
    Ann Emerg Med; 2008 Jan; 51(1):25-34. PubMed ID: 17949853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic monitoring strategies in heart failure management.
    Piccini JP; Hranitzky P
    Am Heart J; 2007 Apr; 153(4 Suppl):12-7. PubMed ID: 17394898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study.
    Moe GW; Howlett J; Januzzi JL; Zowall H;
    Circulation; 2007 Jun; 115(24):3103-10. PubMed ID: 17548729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
    Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
    Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
    van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
    Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathophysiology of acute decompensated heart failure.
    Summers RL; Amsterdam E
    Heart Fail Clin; 2009 Jan; 5(1):9-17, v. PubMed ID: 19026381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
    Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
    Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module).
    Diercks DB; Fonarow GC; Kirk JD; Jois-Bilowich P; Hollander JE; Weber JE; Wynne J; Mills RM; Yancy C; Peacock WF;
    Am J Cardiol; 2008 Nov; 102(9):1216-9. PubMed ID: 18940295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systolic heart failure: chronic and acute syndromes.
    Chatterjee K; Rame JE
    Crit Care Med; 2008 Jan; 36(1 Suppl):S44-51. PubMed ID: 18158477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.